David Tanne Selected Research

Bezafibrate

1/2022	Adherence to Mediterranean diet and subsequent cognitive decline in men with cardiovascular disease.
12/2020	Overweight, Obesity, and Late-Life Sarcopenia Among Men With Cardiovascular Disease, Israel.
12/2020	Angina pectoris severity and late-life frailty among men with cardiovascular disease.
12/2020	Midlife resting heart rate, but not its visit-to-visit variability, is associated with late-life frailty status in men with coronary heart disease.
1/2019	Plasma Lipids, Apolipoproteins, and Subsequent Cognitive Decline in Men with Coronary Heart Disease.
11/2018	Impaired Cerebral Hemodynamics and Frailty in Patients with Cardiovascular Disease.
9/2018	Physical frailty and cognitive function among men with cardiovascular disease.
9/2017	Tall stature in coronary heart disease patients is associated with decreased risk of frailty in late life.
1/2017	Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease.
3/2009	Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Tanne Research Topics

Disease

54	Stroke (Strokes) 07/2021 - 01/2002
43	Ischemic Stroke 01/2018 - 01/2002
32	Infarction (Infarctions) 01/2022 - 01/2002
25	Coronary Disease (Coronary Heart Disease) 06/2021 - 04/2002
12	Myocardial Infarction 09/2016 - 01/2003
9	Hypertension (High Blood Pressure) 01/2017 - 06/2002
8	Cognitive Dysfunction 01/2022 - 11/2006
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2006
6	Atrial Fibrillation 01/2018 - 01/2006
6	Insulin Resistance 01/2018 - 04/2006
6	Coronary Artery Disease (Coronary Atherosclerosis) 04/2011 - 09/2004
5	Inflammation (Inflammations) 06/2021 - 09/2002
5	Dementia (Dementias) 01/2021 - 08/2004
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2016 - 05/2002
4	Frailty 12/2020 - 09/2018
4	Brain Ischemia (Cerebral Ischemia) 01/2020 - 02/2010
4	Vascular Diseases (Vascular Disease) 01/2015 - 01/2003
4	Thrombosis (Thrombus) 01/2012 - 03/2006
4	Cerebral Hemorrhage 04/2010 - 04/2002
3	Hemorrhage 11/2018 - 09/2009
3	Ischemia 01/2018 - 01/2012
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017 - 11/2013
3	Transient Ischemic Attack 04/2016 - 10/2004
3	Sudden Death 01/2007 - 07/2006
2	Atherosclerosis 01/2021 - 03/2006
2	Dyslipidemias (Dyslipidemia) 01/2021 - 04/2006
2	Heart Diseases (Heart Disease) 01/2018 - 04/2002
2	Neoplasms (Cancer) 01/2018 - 06/2008
2	Acute Coronary Syndrome 01/2012 - 12/2007
2	Heart Failure 01/2012 - 11/2006
2	Parkinson Disease (Parkinson's Disease) 04/2011 - 11/2006
2	Psychotic Disorders (Schizoaffective Disorder) 04/2011 - 11/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2008 - 05/2005
2	Hyperglycemia 03/2007 - 05/2003
2	Obesity 04/2006 - 05/2005
1	Embolic Stroke 06/2021
1	Sarcopenia 12/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020

Drug/Important Bio-Agent (IBA)

28	BezafibrateIBA 01/2022 - 01/2002
11	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2011 - 01/2002
9	Thrombin FDA Link 01/2018 - 07/2006
9	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 04/2002
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2021 - 07/2009
7	LipidsIBA 01/2019 - 01/2002
6	HDL CholesterolIBA 01/2012 - 05/2002
6	Triglycerides (Triacylglycerol)IBA 01/2012 - 10/2004
6	CholesterolIBA 01/2012 - 05/2002
5	C-Reactive ProteinIBA 04/2020 - 07/2006
5	ORALIT (ORS)IBA 01/2020 - 02/2010
4	LDL CholesterolIBA 01/2021 - 05/2002
4	Indicators and Reagents (Reagents)IBA 01/2020 - 03/2002
4	AnticoagulantsIBA 11/2018 - 08/2012
4	Pioglitazone (Actos)FDA Link 01/2018 - 12/2014
4	CalciumIBA 01/2017 - 06/2002
4	HomocysteineIBA 01/2007 - 03/2003
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2003 - 04/2002
3	Insulin (Novolin)FDA Link 01/2018 - 12/2014
3	Antihypertensive Agents (Antihypertensives)IBA 02/2016 - 03/2002
3	Warfarin (Coumadin)FDA LinkGeneric 08/2015 - 01/2006
3	Pharmaceutical PreparationsIBA 12/2014 - 02/2004
3	Fibric Acids (Fibrates)IBA 01/2012 - 08/2006
3	Fibrinogen (Factor I)FDA Link 07/2006 - 09/2002
3	fibric acidIBA 07/2006 - 05/2005
2	DiureticsIBA 07/2021 - 01/2017
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 01/2009
2	desirudin (Iprivask)FDA Link 01/2021 - 01/2020
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 07/2008
2	ApolipoproteinsIBA 01/2019 - 07/2008
2	Apolipoproteins B (ApoB)IBA 01/2019 - 07/2008
2	Cytidine Triphosphate (CTP)IBA 07/2018 - 09/2017
2	AntibodiesIBA 01/2017 - 01/2003
2	Antiphospholipid AntibodiesIBA 01/2017 - 04/2008
2	CreatinineIBA 10/2016 - 07/2006
2	Uric Acid (Urate)IBA 01/2015 - 04/2006
2	Interleukin-6 (Interleukin 6)IBA 09/2014 - 07/2006
2	Levodopa (L Dopa)FDA LinkGeneric 04/2011 - 11/2006
2	LigandsIBA 06/2008 - 03/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2008 - 04/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 03/2006
2	HDL LipoproteinsIBA 03/2008 - 10/2004
2	Immunoglobulin G (IgG)IBA 01/2003 - 03/2002
1	InterleukinsIBA 06/2021
1	Colchicine FDA LinkGeneric 06/2021
1	Tubulin ModulatorsIBA 06/2021
1	Ezetimibe (Zetia)FDA Link 01/2021
1	PCSK9 InhibitorsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	low density lipoprotein inhibitorIBA 01/2021
1	Apolipoproteins AIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	apixabanIBA 01/2018
1	triphenyltetrazoliumIBA 01/2018

Therapy/Procedure

29	Therapeutics 06/2021 - 03/2002
19	Secondary Prevention 06/2021 - 01/2002
4	Thrombolytic Therapy 09/2009 - 01/2002
3	Length of Stay 07/2021 - 01/2006
2	Thrombectomy 01/2021 - 12/2019
2	Transcranial Magnetic Stimulation 01/2020 - 01/2019
2	Contraindications 01/2017 - 11/2011
1	Mediterranean Diet 01/2022